PCI BIOTECH HOLDING ASA (PCIB.OL) Fundamental Analysis & Valuation

OSL:PCIB • NO0010405640

Current stock price

0.155 NOK
-0.01 (-4.62%)
Last:

This PCIB.OL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. PCIB.OL Profitability Analysis

1.1 Basic Checks

  • PCIB had negative earnings in the past year.
  • In the past year PCIB has reported a negative cash flow from operations.
  • In the past 5 years PCIB always reported negative net income.
  • In the past 5 years PCIB always reported negative operating cash flow.
PCIB.OL Yearly Net Income VS EBIT VS OCF VS FCFPCIB.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

  • With a Return On Assets value of -88.63%, PCIB is not doing good in the industry: 78.57% of the companies in the same industry are doing better.
  • PCIB's Return On Equity of -131.18% is on the low side compared to the rest of the industry. PCIB is outperformed by 60.71% of its industry peers.
Industry RankSector Rank
ROA -88.63%
ROE -131.18%
ROIC N/A
ROA(3y)-61.83%
ROA(5y)-57.01%
ROE(3y)-72.67%
ROE(5y)-66.77%
ROIC(3y)N/A
ROIC(5y)N/A
PCIB.OL Yearly ROA, ROE, ROICPCIB.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200

1.3 Margins

  • PCIB does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PCIB.OL Yearly Profit, Operating, Gross MarginsPCIB.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 -500 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. PCIB.OL Health Analysis

2.1 Basic Checks

  • PCIB does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for PCIB remains at a similar level compared to 1 year ago.
  • PCIB has about the same amout of shares outstanding than it did 5 years ago.
  • The debt/assets ratio for PCIB is higher compared to a year ago.
PCIB.OL Yearly Shares OutstandingPCIB.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
PCIB.OL Yearly Total Debt VS Total AssetsPCIB.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • PCIB has an Altman-Z score of -0.61. This is a bad value and indicates that PCIB is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of PCIB (-0.61) is worse than 63.10% of its industry peers.
  • There is no outstanding debt for PCIB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.61
ROIC/WACCN/A
WACC8.32%
PCIB.OL Yearly LT Debt VS Equity VS FCFPCIB.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • PCIB has a Current Ratio of 2.94. This indicates that PCIB is financially healthy and has no problem in meeting its short term obligations.
  • PCIB's Current ratio of 2.94 is in line compared to the rest of the industry. PCIB outperforms 59.52% of its industry peers.
  • PCIB has a Quick Ratio of 2.94. This indicates that PCIB is financially healthy and has no problem in meeting its short term obligations.
  • PCIB's Quick ratio of 2.94 is fine compared to the rest of the industry. PCIB outperforms 61.90% of its industry peers.
Industry RankSector Rank
Current Ratio 2.94
Quick Ratio 2.94
PCIB.OL Yearly Current Assets VS Current LiabilitesPCIB.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. PCIB.OL Growth Analysis

3.1 Past

  • PCIB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 19.20%, which is quite good.
  • The Revenue has grown by 125.25% in the past year. This is a very strong growth!
  • The Revenue has been decreasing by -6.43% on average over the past years.
EPS 1Y (TTM)19.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-55.67%
Revenue 1Y (TTM)125.25%
Revenue growth 3Y2.4%
Revenue growth 5Y-6.43%
Sales Q2Q%-59.75%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PCIB.OL Yearly Revenue VS EstimatesPCIB.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
PCIB.OL Yearly EPS VS EstimatesPCIB.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 -0.5 -1 -1.5 -2

More info and screens

Find the best growth stocksShow best growing peers

0

4. PCIB.OL Valuation Analysis

4.1 Price/Earnings Ratio

  • PCIB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PCIB.OL Price Earnings VS Forward Price EarningsPCIB.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PCIB.OL Per share dataPCIB.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PCIB.OL Dividend Analysis

5.1 Amount

  • PCIB does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PCIB.OL Fundamentals: All Metrics, Ratios and Statistics

PCI BIOTECH HOLDING ASA

OSL:PCIB (4/17/2026, 7:00:00 PM)

0.155

-0.01 (-4.62%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)N/A
Earnings (Next)08-29
Inst Owners5.73%
Inst Owner ChangeN/A
Ins Owners9.06%
Ins Owner ChangeN/A
Market Cap5.79M
Revenue(TTM)6.74M
Net Income(TTM)-16.42M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.86
P/FCF N/A
P/OCF N/A
P/B 0.46
P/tB 0.46
EV/EBITDA N/A
EPS(TTM)-0.44
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.44
FCFYN/A
OCF(TTM)-0.42
OCFYN/A
SpS0.18
BVpS0.34
TBVpS0.34
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -88.63%
ROE -131.18%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-61.83%
ROA(5y)-57.01%
ROE(3y)-72.67%
ROE(5y)-66.77%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.94
Quick Ratio 2.94
Altman-Z -0.61
F-Score4
WACC8.32%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)19.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-55.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)125.25%
Revenue growth 3Y2.4%
Revenue growth 5Y-6.43%
Sales Q2Q%-59.75%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y19.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y45.41%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y47.5%
OCF growth 3YN/A
OCF growth 5YN/A

PCI BIOTECH HOLDING ASA / PCIB.OL Fundamental Analysis FAQ

What is the fundamental rating for PCIB stock?

ChartMill assigns a fundamental rating of 2 / 10 to PCIB.OL.


What is the valuation status of PCI BIOTECH HOLDING ASA (PCIB.OL) stock?

ChartMill assigns a valuation rating of 0 / 10 to PCI BIOTECH HOLDING ASA (PCIB.OL). This can be considered as Overvalued.


How profitable is PCI BIOTECH HOLDING ASA (PCIB.OL) stock?

PCI BIOTECH HOLDING ASA (PCIB.OL) has a profitability rating of 0 / 10.


What is the financial health of PCI BIOTECH HOLDING ASA (PCIB.OL) stock?

The financial health rating of PCI BIOTECH HOLDING ASA (PCIB.OL) is 6 / 10.